US FDA approves GSK’s Blujepa as oral option for treatment of uncomplicated urogenital gonorrhoea: London, UK Saturday, December 13, 2025, 09:00 Hrs [IST] GSK plc announced that ...

The company now intends to request a re-examination of the opinion which would be undertaken by a different set of reviewers ...

As for the overall party looks for the ladies this holiday season, the theme is understated elegance with rich tones paired ...

The federal government on Monday unveiled the national policy on drug and substance abuse in schools, marking a significant step toward tackling the rising rate of addiction among students in ...

The Delamere clinic, Cuddington, applied for planning permission for an extension last year after its launch in 2020 . The application was for extra therapy rooms and treatment rooms on the ground ...

On Friday, the F.D.A. approved a new antibiotic, zoliflodacin, a day after an article published in The Lancet reported that a ...

And GSK announced Thursday that the FDA had approved its medication gepotidacin, with the brand name Blujepa, as oral tablets ...

The U.S. health regulator on Friday approved Innoviva's oral antibiotic to treat gonorrhea, a common sexually transmitted infection, offering patients an alternative to an injectable drug that was the ...

For the first time in nearly 40 years, patients with uncomplicated urogenital gonorrhea have new oral treatment options.

Researchers found a chasm between the health reasons for which the public seeks out cannabis and what gold-standard science ...